Cite

HARVARD Citation

    Kornmann, O. et al. (n.d.). P223 Once-daily low-dose indacaterol/mometasone via breezhaler® reduces exacerbations in patients with inadequately controlled asthma: phase III QUARTZ study. Thorax. pp. A209-A210. [Online]. 
  
Back to record